Gentian Diagnostics ASA (OB:GENT) entered into an agreement to acquire Getica Ab from Erling Sundrehagen for SEK 3 million on June 15, 2023. The closing is expected to take place in early July.
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
40.4 NOK | +1.51% | +7.45% | -2.65% |
Apr. 29 | Gentian Diagnostics Asa Resolves to Elect Ms. Hilja Ibert as Chairperson of the Board of Directors | CI |
Apr. 29 | Gentian Diagnostics ASA Appoints Mr. Njaal Kind as Acting CEO | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.65% | 55.83M | |
+0.70% | 12.95B | |
-7.57% | 7.84B | |
+1.91% | 5.5B | |
+0.93% | 4.61B | |
+8.48% | 4.61B | |
-49.25% | 3.4B | |
+9.21% | 2.66B | |
-14.59% | 2.08B | |
+3.45% | 1.79B |
- Stock Market
- Equities
- GENT Stock
- News Gentian Diagnostics
- Gentian Diagnostics ASA (OB: GENT) entered into an agreement to acquire Getica Ab from Erling Sundrehagen for SEK 3 million.